• FirefoxInstall the new Firefox »
  •  Dow Up0.19% Nasdaq Up0.57%

    Spectrum Pharmaceuticals, Inc. (SPPI)

    -NasdaqGS
    6.01 Up 0.06(0.92%) Mar 27, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 51,861   47,990   46,855   40,124  
    Cost of Revenue8,073  6,530  6,156  6,278  
    Gross Profit 43,788   41,460   40,699   33,846  
    Operating Expenses
    Research Development14,410  14,420  11,335  29,497  
    Selling General and Administrative24,485  24,125  25,399  23,403  
    Non Recurring -   -   -   -  
    Others6,525  7,042  5,361  5,360  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (1,632) (4,127) (1,396) (24,414)
    Income from Continuing Operations
    Total Other Income/Expenses Net768  (1,574)(1,492)(1,082)
    Earnings Before Interest And Taxes(864)(5,701)(2,888)(25,496)
    Interest Expense2,180  2,361  1,976  2,067  
    Income Before Tax(3,044)(8,062)(4,864)(27,563)
    Income Tax Expense(68)3,477  (1,301)78  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(2,976)(11,539)(3,563)(27,641)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (2,976) (11,539) (3,563) (27,641)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (2,976) (11,539) (3,563) (27,641)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.